MIR3688-1

Across TCGA pan-cancer cohorts, MIR3688-1 RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated MIR3688-1 data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher MIR3688-1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR3688-1 expression acts as an unfavorable survival marker, although some lineages such as ESCA and COAD show a favorable association.

BLCA, READ, and UCEC are the cancer types where MIR3688-1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	OS	Tertile	IV	0.152	0.604	<.001	36	view →
READ	DFS	Tertile	III,IV	0.027	0.761	<.001	36	view →
UCEC	DFS	Tertile	All	0.793	0.898	.003	36	view →
STAD	DFS	Tertile	All	0.484	0.743	.002	27	view →
PAAD	OS	Tertile	II,III,IV	0.277	0.560	.009	18	view →
KIRC	DFS	Tertile	IV	0.256	0.617	.005	18	view →
UCS	OS	Tertile	All	0.226	0.590	.031	18	view →
ESCA	DFS	Tertile	All	0.668	0.496	.039	9	view →
COAD	DFS	Tertile	All	0.932	0.502	.039	6	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

MIR3688-1–BLCA (OS)

Open the BLCA breakdown →